Recurrence pattern in patients with a pathologically complete response after neoadjuvant chemoradiotherapy and surgery for oesophageal cancer

British Journal of Surgery

Volumn 100, Issue 2, 2013, Pages 267-273

  Van Hagen, P ^a   Wijnhoven, B P L ^a   Nafteux, P ^b   Moons, J ^b   Haustermans, K ^b   De Hertogh, G ^b   Van Lanschot, J J B ^a   Lerut, T ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT CHEMORADIOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; CHEMORADIOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES;

EID: 84871296715     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.8968     Document Type: Article

References (23)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM,. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917.
2. Parkin DM, Bray FI, Devesa SS,. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001; 37 (Suppl 8): S4-S66.
3. Gannett DE, Wolf RF, Takahashi GW, Louie J, Wagner RC, Ey FS, et al., Neoadjuvant chemoradiotherapy for esophageal cancer using weekly paclitaxel and carboplatin plus infusional 5-fluorouracil. Gastrointest Cancer Res 2007; 1: 132-138.
4. Lin CC, Hsu CH, Cheng JC, Wang HP, Lee JM, Yeh KH, et al., Concurrent chemoradiotherapy with twice weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal cancer. Ann Oncol 2007; 18: 93-98.
5. van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, et al.,; Cross Group. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 2012; 366: 2074-2084.
6. Burmeister BH, Smithers BM, Gebski V, Fitzgerald L, Simes RJ, Devitt P, et al.,; Trans-Tasman Radiation Oncology Group; Australasian Gastro-Intestinal Trials Group. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol 2005; 6: 659-668.
7. Tepper J, Krasna MJ, Niedzwiecki D, Hollis D, Reed CE, Goldberg R, et al., Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 2008; 26: 1086-1092.
8. Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M,. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001; 19: 305-313.
9. Schneider PM, Baldus SE, Metzger R, Kocher M, Bongartz R, Bollschweiler E, et al., Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification. Ann Surg 2005; 242: 684-692.
10. Mandard AM, Dalibard F, Mandard JC, Marnay J, Henry-Amar M, Petiot JF, et al., Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 1994; 73: 2680-2686.
11. Lerut T, De Leyn P, Coosemans W, Van Raemdonck D, Scheys I, LeSaffre E,. Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy. Ann Surg 1992; 216: 583-590.
12. Müller JM, Erasmi H, Stelzner M, Zieren U, Pichlmaier H,. Surgical therapy of oesophageal carcinoma. Br J Surg 1990; 77: 845-857.
13. Singletary SE, Greene FL, Sobin LH,. Classification of isolated tumor cells: clarification of the 6th edition of the American Joint Committee on Cancer Staging Manual. Cancer 2003; 98: 2740-2741.
14. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, et al., (eds). AJCC Cancer Staging Manual (6th edn). Springer: New York, 2002.
15. Lerut T, Nafteux P, Moons J, Coosemans W, Decker G, De Leyn P, et al., Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg 2004; 240: 962-972.
16. Lee PC, Mirza FM, Port JL, Stiles BM, Paul S, Christos P, et al., Predictors of recurrence and disease-free survival in patients with completely resected esophageal carcinoma. J Thorac Cardiovasc Surg 2011; 141: 1196-1206.
17. Hagen JA, DeMeester SR, Peters JH, Chandrasoma P, DeMeester TR,. Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg 2001; 234: 520-530.
18. Reynolds JV, Muldoon C, Hollywood D, Ravi N, Rowley S, O'Byrne K, et al., Long-term outcomes following neoadjuvant chemoradiotherapy for esophageal cancer. Ann Surg 2007; 245: 707-716.
19. Meguid RA, Hooker CM, Taylor JT, Kleinberg LR, Cattaneo SM II, Sussman MS, et al., Recurrence after neoadjuvant chemoradiation and surgery for esophageal cancer: does the pattern of recurrence differ for patients with complete response and those with partial or no response? J Thorac Cardiovasc Surg 2009; 138: 1309-1317.
20. Rohatgi PR, Swisher SG, Correa AM, Wu TT, Liao Z, Komaki R, et al., Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus. Cancer 2005; 104: 1349-1355.
21. Rizzetto C, DeMeester SR, Hagen JA, Peyre CG, Lipham JC, DeMeester TR,. En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma. J Thorac Cardiovasc Surg 2008; 135: 1228-1236.
22. Hennequin C, Favaudon V,. Biological basis for chemo-radiotherapy interactions. Eur J Cancer 2002; 38: 223-230.
23. Allum WH, Stenning SP, Bancewicz J, Clark PI, Langley RE,. Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J Clin Oncol 2009; 27: 5062-5067.